232 related articles for article (PubMed ID: 8750747)
1. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship.
Van Bergen P; Janssen PM; Hoogerhout P; De Wildt DJ; Versteeg DH
Eur J Pharmacol; 1995 Dec; 294(2-3):795-803. PubMed ID: 8750747
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats.
Van Bergen P; Van Der Vaart JG; Kasbergen CM; Versteeg DH; De Wildt DJ
Eur J Pharmacol; 1996 Dec; 318(2-3):357-68. PubMed ID: 9016926
[TBL] [Abstract][Full Text] [Related]
3. Melanocortins and cardiovascular regulation.
Versteeg DH; Van Bergen P; Adan RA; De Wildt DJ
Eur J Pharmacol; 1998 Oct; 360(1):1-14. PubMed ID: 9845266
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamic effects of gamma 2-melanocyte-stimulating hormone and related melanotropins depend on the arousal potential of the rat.
De Wildt DJ; Krugers H; Kasbergen CM; De Lang H; Versteeg DH
Eur J Pharmacol; 1993 Mar; 233(1):157-64. PubMed ID: 8386086
[TBL] [Abstract][Full Text] [Related]
5. Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24).
Van Bergen P; Kleijne JA; De Wildt DJ; Versteeg DH
Br J Pharmacol; 1997 Apr; 120(8):1561-7. PubMed ID: 9113379
[TBL] [Abstract][Full Text] [Related]
6. Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats.
Nijsen MJ; de Ruiter GJ; Kasbergen CM; Hoogerhout P; de Wildt DJ
Br J Pharmacol; 2000 Dec; 131(7):1468-74. PubMed ID: 11090122
[TBL] [Abstract][Full Text] [Related]
7. ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides.
Gruber KA; Callahan MF
Am J Physiol; 1989 Oct; 257(4 Pt 2):R681-94. PubMed ID: 2552843
[TBL] [Abstract][Full Text] [Related]
8. A study on possible modulating and direct effects of gamma2-MSH and ACTH-(1-24) on the cardiovascular system of the rat.
Van Bergen P; Vleeming W; Van Heijst BG; Versteeg DH; De Wildt DJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):220-9. PubMed ID: 9750008
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of melanocortin peptides on neural melanocortin receptors.
Adan RA; Cone RD; Burbach JP; Gispen WH
Mol Pharmacol; 1994 Dec; 46(6):1182-90. PubMed ID: 7808440
[TBL] [Abstract][Full Text] [Related]
10. Identification of antagonists for melanocortin MC3, MC4 and MC5 receptors.
Adan RA; Oosterom J; Ludvigsdottir G; Brakkee JH; Burbach JP; Gispen WH
Eur J Pharmacol; 1994 Nov; 269(3):331-7. PubMed ID: 7895772
[TBL] [Abstract][Full Text] [Related]
11. Pressor and cardioaccelerator effects of gamma MSH and related peptides.
Klein MC; Hutchins PM; Lymangrover JR; Gruber KA
Life Sci; 1985 Feb; 36(8):769-75. PubMed ID: 2983170
[TBL] [Abstract][Full Text] [Related]
12. Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors.
Mioni C; Giuliani D; Cainazzo MM; Leone S; Bazzani C; Grieco P; Novellino E; Tomasi A; Bertolini A; Guarini S
Eur J Pharmacol; 2003 Sep; 477(3):227-34. PubMed ID: 14522361
[TBL] [Abstract][Full Text] [Related]
13. Effect of ACTH-(4-10) and gamma 2-MSH on blood pressure after intracerebroventricular and intracisternal administration.
Versteeg DH; Krugers H; Meichow C; de Lang H; De Wildt DJ
J Cardiovasc Pharmacol; 1993 Jun; 21(6):907-11. PubMed ID: 7687715
[TBL] [Abstract][Full Text] [Related]
14. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones.
Li SJ; Varga K; Archer P; Hruby VJ; Sharma SD; Kesterson RA; Cone RD; Kunos G
J Neurosci; 1996 Aug; 16(16):5182-8. PubMed ID: 8756446
[TBL] [Abstract][Full Text] [Related]
15. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis.
Suzuki I; Cone RD; Im S; Nordlund J; Abdel-Malek ZA
Endocrinology; 1996 May; 137(5):1627-33. PubMed ID: 8612494
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of frog (Rana ridibunda Pallas) interrenal function by use of a simplified perifusion system. VIII. Structure-activity relationship of synthetic ACTH fragments and gamma-MSH.
Leboulenger F; Lihrmann I; Netchitailo P; Delarue C; Perroteau I; Ling N; Vaudry H
Gen Comp Endocrinol; 1986 Feb; 61(2):187-96. PubMed ID: 3007266
[TBL] [Abstract][Full Text] [Related]
17. Gamma-MSH and its related peptides do not augment ACTH-induced steroidogenesis in isolated rat adrenal cells.
Moriwaki K; Iida S; Gomi M; Tsugawa M; Itoh Y
Endocrinol Jpn; 1985 Aug; 32(4):563-8. PubMed ID: 3002771
[TBL] [Abstract][Full Text] [Related]
18. Role of chain termini in selective steroidogenic effect of ACTH/MSH(4-10) on isolated adrenocortical cells.
Löw M; Szalay KS; Kisfaludy L
Peptides; 1990; 11(1):29-31. PubMed ID: 2160651
[TBL] [Abstract][Full Text] [Related]
19. Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors.
Oosterom J; Nijenhuis WA; Schaaper WM; Slootstra J; Meloen RH; Gispen WH; Burbach JP; Adan RA
J Biol Chem; 1999 Jun; 274(24):16853-60. PubMed ID: 10358030
[TBL] [Abstract][Full Text] [Related]
20. Asp10 in Lys-gamma2-MSH determines selective activation of the melanocortin MC3 receptor.
Oosterom J; Burbach JP; Gispen WH; Adan RA
Eur J Pharmacol; 1998 Jul; 354(1):R9-11. PubMed ID: 9726642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
